Skip to content
Forensic Analysis · Chemicals · as of Nov 9, 2026

Ingevity Corp (NGVT)

A forensic read on Ingevity Corp built from its complete SEC filings — financial-health screens, earnings quality, red flags and a price-aware rating. Reproducible math, not opinion.

B · Sound & dependable
Forensic grade
Clean
Earnings quality
1
Forensic signals
-148.6%
ROE
-2.7%
Revenue growth

This free snapshot doesn't read filing or proxy text, so the auditor-quality and governance checks that can lower a grade were not evaluated (auditor quality, say on pay, board independence, going concern). Those checks only ever lower a grade, so the full analysis can land below the grade above but never above it — treat it as the most favourable reading, not the settled one.

Ingevity Corp earns a B (Sound & dependable) forensic quality grade. 1 forensic signal was flagged in its latest SEC filings, led by goodwill impairments.

What the filings flag

$490M
FY2024–FY2025
Goodwill impairments. Took $490M of goodwill writedowns across 2 years (FY2024 ($307M), FY2025 ($184M)). Writedowns mean past acquisitions underperformed what was paid for them.

Key fundamentals

Latest Revenue$1.17B
Revenue Growth YoY-2.7%
Revenue CAGR (2yr)-2.0%
Net Margin-14.3%
Free Cash Flow$273.5M
Return on Equity-148.6%

The forensic grade and screens above are free — no account needed. Want the AI investment read on top — the 0–100 rating, thesis, bull-vs-bear, red flags and the 12-month scenario, written from Ingevity Corp's actual 10-K/10-Q/8-K filings?

Generate the AI investment read →

No credit card · informational only, not investment advice · see the track record

← Browse all forensic stock analyses

Data from SEC EDGAR public filings · metrics as of Nov 9, 2026. Forensic signals flag probability, not certainty.

See a wrong number? Report an error with the filing it should match.